Immuron IMRN
NASDAQ IMRN
$0.95 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Immuron (IMRN) Cost of Revenue (2023 - 2024)

Updated

Immuron (IMRN) posted Cost of Revenue of $2.74 million for FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) Cost of Revenue (2023 - 2024) Analysis & Trends

Since FY2015, Immuron has reported Cost of Revenue for 12 fiscal years.

  • Annual Cost of Revenue shows a five-year compound annual growth rate of 136.0% (FY2021 to FY2026).
  • The FY2026 figure stands as the highest annual Cost of Revenue in data going back to FY2015.
  • Business Quant data shows IMRN's Cost of Revenue at $2.52 million in FY2025, $15,661 in FY2024 (-98.0%), $775,232 in FY2023 (+397.8%) and $155,726 in FY2022 (+316.5%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.27 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 8.10 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 4.29 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 4.40 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 3.71 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 2.52 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 2.81 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.58 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 4.09 Bn
10 Immuron 7.67 Mn -9.48 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.02 Mn
Sep 9, 2024 10,435.26
Dec 31, 2023 3,226.04
API Access

Immuron Cost of Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=IMRN&period=max&api_key=YOUR_API_KEY